{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:44:35Z","timestamp":1792100675237,"version":"4.4.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.celrep.2026.117961","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:54:01Z","timestamp":1789088041000},"page":"117961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations"],"prefix":"10.1016","volume":"45","author":[{"given":"Jessica","family":"Desjardins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Bowlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9o","family":"Goullet de Rugy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Orcholski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Laterreur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abira","family":"Rajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lafontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexanda","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse H.","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Durocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Roulston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"\u00c1lvarez-Quil\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan T.F.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117961_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","volume":"4","author":"Andrew","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.117961_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2018.12.001","article-title":"Oncogene addiction as a foundation of targeted cancer therapy: The paradigm of the MET receptor tyrosine kinase","volume":"443","author":"Orlando","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2026.117961_bib3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/2159-8290.CD-20-1503","article-title":"Synthetic Lethality in Cancer Therapeutics: The Next Generation","volume":"11","author":"Setton","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117961_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s43018-023-00516-z","article-title":"Advances in antibody-based therapy in oncology","volume":"4","author":"Zinn","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117961_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2026.117961_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.117961_bib7","article-title":"Synthetic lethal strategies for the development of cancer therapeutics","volume":"22","author":"Nyl","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117961_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102410","article-title":"Therapeutic advances and application of PARP inhibitors in breast cancer","volume":"57","author":"Zhou","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.celrep.2026.117961_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s43586-021-00093-4","article-title":"High-content CRISPR screening","volume":"2","author":"Bock","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.celrep.2026.117961_bib10","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","article-title":"Aregger. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities","volume":"163","author":"Hart","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib11","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1038\/s41467-019-13805-y","article-title":"Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets","volume":"10","author":"Dempster","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117961_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm6638","article-title":"Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors","volume":"8","author":"Feng","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117961_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-022-04638-9","article-title":"CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition","volume":"604","author":"Gallo","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature14157","article-title":"Mammalian polymerase \u03b8 promotes alternative NHEJ and suppresses recombination","volume":"518","author":"Mateos-Gomez","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib15","article-title":"A dual mechanism of sensitivity to PLK4 inhibition by RP-1664 in neuroblastoma","author":"Soria-Bretones","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2026.117961_bib16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41586-020-2710-1","article-title":"TRIM37 controls cancer-specific vulnerability to PLK4 inhibition","volume":"585","author":"Meitinger","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib17","article-title":"WRN helicase is a synthetic lethal target in microsatellite unstable cancers","volume":"568","author":"Edmond","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-024-07350-y","article-title":"Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers","volume":"629","author":"Ferretti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41586-024-07318-y","article-title":"Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase","volume":"629","author":"Baltgalvis","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/1535-7163.MCT-24-0515","article-title":"Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination Deficiency","volume":"24","author":"Simoneau","year":"2025","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.celrep.2026.117961_bib21","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-24-0293","article-title":"The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination\u2013Deficient Tumors","volume":"84","author":"Cadzow","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117961_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2020.12.010","article-title":"MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage","volume":"39","author":"Kalev","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.aad5214","article-title":"MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells","volume":"351","author":"Kryukov","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117961_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.celrep.2016.03.043","article-title":"MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A\/PRMT5\/RIOK1 Axis","volume":"15","author":"Marjon","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117961_bib25","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117961_bib26","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1534\/g3.117.041277","article-title":"Evaluation and Design of Genome-Wide CRISPR\/SpCas9 Knockout Screens","volume":"7","author":"Hart","year":"2017","journal-title":"G3 (Bethesda)."},{"key":"10.1016\/j.celrep.2026.117961_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00809-3","article-title":"Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier","volume":"13","author":"Kim","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.celrep.2026.117961_bib28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s43018-021-00266-w","article-title":"The CIP2A\u2013TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer","volume":"2","author":"Adam","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117961_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nm.3480","article-title":"ARID1B is a specific vulnerability in ARID1A-mutant cancers","volume":"20","author":"C","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.117961_bib30","article-title":"CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13","volume":"5","author":"Tien","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2026.117961_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109367","article-title":"Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q","volume":"36","author":"Neggers","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117961_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030420","article-title":"Dysfunctional KEAP1\u2013NRF2 Interaction in Non-Small-Cell Lung Cancer","volume":"3","author":"Singh","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.celrep.2026.117961_bib33","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117961_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Jordi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2026.117961_bib36","article-title":"Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals","volume":"300","author":"Liu","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117961_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41416-023-02324-9","article-title":"Rethinking our approach to cancer metabolism to deliver patient benefit","volume":"129","author":"Tardito","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.117961_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1480613","article-title":"Bridging the gap: advancing cancer cell culture to reveal key metabolic targets","volume":"14","author":"Kes","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2026.117961_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/geno.1999.5785","article-title":"cDNA Cloning and Mapping of a Novel Subtype of Glutamine:fructose-6-phosphate Amidotransferase (GFAT2) in Human and Mouse","volume":"57","author":"Oki","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.celrep.2026.117961_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109597","article-title":"Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome","volume":"36","author":"Parrish","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117961_bib41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2026.117961_bib42","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-021-00967-z","article-title":"Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers","volume":"53","author":"Ito","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2026.117961_bib43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.cub.2004.08.021","article-title":"aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity","volume":"14","author":"Suzuki","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.celrep.2026.117961_bib44","doi-asserted-by":"crossref","first-page":"16986","DOI":"10.1073\/pnas.1215450109","article-title":"Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages","volume":"109","author":"Clark","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.celrep.2026.117961_bib45","doi-asserted-by":"crossref","first-page":"10251","DOI":"10.1021\/acs.jmedchem.2c00552","article-title":"Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306","volume":"65","author":"Szychowski","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.celrep.2026.117961_bib46","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1158\/0008-5472.CAN-15-3342","article-title":"Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth","volume":"76","author":"Haesen","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117961_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ccell.2014.09.013","article-title":"Clurman. Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib48","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41587-021-01172-3","article-title":"Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants","volume":"40","author":"S\u00e1nchez-Rivera","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117961_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.1065203","article-title":"Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCF Fbw7 Ubiquitin Ligase","volume":"294","author":"Koepp","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117961_bib50","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.cub.2004.09.083","article-title":"A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase Regulates c-Myc and Cell Size","volume":"14","author":"Welcker","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.celrep.2026.117961_bib51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2007.05.027","article-title":"Sequential E2s Drive Polyubiquitin Chain Assembly on APC Targets","volume":"130","author":"Rodrigo-Brenni","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.molcel.2014.09.009","article-title":"Weissmann. Mechanism of Polyubiquitination by Human Anaphase-Promoting Complex: RING Repurposing for Ubiquitin Chain Assembly","volume":"56","author":"Brown","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.molcel.2011.04.022","article-title":"Regulation of Ubiquitin Chain Initiation to Control the Timing of Substrate Degradation","volume":"42","author":"Williamson","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cell.2008.04.012","article-title":"Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex","volume":"133","author":"Jin","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib55","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41586-024-08509-3","article-title":"SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO","volume":"638","author":"Borck","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib56","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41586-024-08398-6","article-title":"Synthetic lethality of mRNA quality control complexes in cancer","volume":"638","author":"Prindle","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajh.23373","article-title":"Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance","volume":"88","author":"Patnaik","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.celrep.2026.117961_bib58","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/0008-5472.CAN-21-1843","article-title":"Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors","volume":"82","author":"Lappin","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117961_bib59","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41588-023-01460-5","article-title":"SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response","volume":"55","author":"Bland","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2026.117961_bib60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-018-0340-7","article-title":"The shieldin complex mediates 53BP1-dependent DNA repair","volume":"560","author":"Noordermeer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2018.12.009","article-title":"Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers","volume":"35","author":"Ogiwara","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","article-title":"Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma","volume":"2","author":"Wu","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117961_bib63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.117961_bib64","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2021.01.041","article-title":"Functional interrogation of DNA damage response variants with base editing screens","volume":"184","author":"Cuella-Martin","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/hum.2024.043","article-title":"Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and Challenges","volume":"35","author":"Hosseini","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.celrep.2026.117961_bib66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.molcel.2005.04.023","article-title":"The WD40 Propeller Domain of Cdh1 Functions as a Destruction Box Receptor for APC\/C Substrates","volume":"18","author":"Kraft","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib67","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2008.09.023","article-title":"A Role for the Fizzy\/Cdc20 Family of Proteins in Activation of the APC\/C Distinct from Substrate Recruitment","volume":"32","author":"Kimata","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib68","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1083\/jcb.149.7.1377","article-title":"Phosphorylation by Cdc28 Activates the Cdc20-Dependent Activity of the Anaphase-Promoting Complex","volume":"149","author":"Rudner","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117961_bib69","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1091\/mbc.11.5.1555","article-title":"Mitotic Regulation of the APC Activator Proteins CDC20 and CDH1","volume":"11","author":"Kramer","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.celrep.2026.117961_bib70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1083\/jcb.200703202","article-title":"Cyclin E overexpression impairs progression through mitosis by inhibiting APCCdh1","volume":"178","author":"Keck","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117961_bib84","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"15","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.celrep.2026.117961_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41586-018-0291-z","article-title":"CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions","volume":"559","author":"Zimmermann","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117961_bib72","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2026.117961_bib73","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.celrep.2026.117961_bib74","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nbt.4194","article-title":"Optimized base editors enable efficient editing in cells, organoids and mice","volume":"36","author":"Zafra","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117961_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100321","article-title":"Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library","volume":"2","author":"Olivieri","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.celrep.2026.117961_bib76","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-019-0665-3","article-title":"Identifying chemogenetic interactions from CRISPR screens with drugZ","volume":"11","author":"Colic","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.celrep.2026.117961_bib77","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2026.117961_bib78","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2026.117961_bib79","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1093\/nar\/gkac161","article-title":"Predicting base editing outcomes using position-specific sequence determinants","volume":"50","author":"Pallaseni","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117961_bib80","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1038\/s41467-022-34320-7","article-title":"A comprehensive Bioconductor ecosystem for the design of CRISPR guide RNAs across nucleases and technologies","volume":"13","author":"Hoberecht","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117961_bib81","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.celrep.2026.117961_bib82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc. B Stat. Methodol."},{"key":"10.1016\/j.celrep.2026.117961_bib83","article-title":"Quantification of 2-Hydroxyglutarate Enantiomers by Liquid Chromatography-mass Spectrometry","volume":"20","author":"Oldham","year":"2016","journal-title":"Bio Protoc"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726010399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726010399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:52:32Z","timestamp":1792097552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726010399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211124726010399"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117961","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117961"}}